|
1) Katanoda K, Marugame T, Saika K, et al. Population attributable fraction of mortality associated with tobacco smoking in Japan: a pooled analysis of three large-scale cohort studies. J Epidemiol/Japan Epidemiological Association. 2008; 18: 251-64
|
|
|
|
2) Sobue T, Yamamoto S, Hara M, et al. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int J Cancer. 2002; 99: 245-51
|
|
|
|
|
|
3) Kurahashi N, Inoue M, Liu Y, et al. Passive smoking and lung cancer in Japanese non-smoking women: a prospective study. Int J Cancer. 2008; 122: 653-7
|
|
|
|
|
|
4) Yu IT, Chiu YL, Au JS, et al. Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women. Cancer Res. 2006; 66: 4961-7
|
|
|
|
|
|
5) Chen F, Jackson H, Bina WF. Lung adeno-carcinoma incidence rates and their relation to motor vehicle density. Cancer Epidemiol Biomarkers Prev. 2009; 18: 760-4
|
|
|
|
|
|
6) Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers─a different disease. Nature reviews. 2007; 7: 778-90
|
|
|
|
|
|
7) Marquez-Garban DC, Chen HW, Fishbein MC, et al. Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids. 2007; 72: 135-43
|
|
|
|
|
|
8) Niikawa H, Suzuki T, Miki Y, et al. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin Cancer Res. 2008; 14: 4417-26
|
|
|
|
|
|
9) Siegfried JM. Women and lung cancer: does oestrogen play a role？ Lancet Oncol. 2001; 2: 506-13
|
|
|
|
|
|
10) Cavalieri E, Rogan E. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Ann NY Acad Sci. 2006; 1089: 286-301
|
|
|
|
|
|
11) Dubey S, Siegfried JM, Traynor AM. Non-small-cell lung cancer and breast carcinoma: chemo-therapy and beyond. Lancet Oncol. 2006; 7: 416-24
|
|
|
|
|
|
12) Stabile LP, Lyker JS, Gubish CT, et al. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res. 2005; 65: 1459-70
|
|
|
|
|
|
13) Liu Y, Inoue M, Sobue T, et al. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer. 2005; 117: 662-6
|
|
|
|
|
|
14) Matsuo K, Ito H, Yatabe Y, et al. Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese. Cancer Sci. 2007; 98: 96-101
|
|
|
|
|
|
15) Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005; 93: 825-33
|
|
|
|
|
|
16) Bell DW, Gore I, Okimoto RA, et al. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat Genet. 2005; 37: 1315-6
|
|
|
|
|
|
17) Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008; 452: 633-7
|
|
|
|
|
|
18) Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008; 452: 638-42
|
|
|
|
|
|
19) Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25. 1. Nat Genet. 2008; 40: 616-22
|
|
|
|
|
|
20) Lam TK, Cross AJ, Consonni D, et al. Intakes of red meat, processed meat, and meat mutagens increase lung cancer risk. Cancer Res. 2009; 69: 932-9
|
|
|
|
|
|
21) Gandhi J, Zhang J, Xie Y, et al. Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS One. 2009; 4: e4576
|
|
|
|
|
|
22) Marks JL, Gong Y, Chitale D, et al. Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma. Cancer Res. 2008; 68: 5524-8
|
|
|
|
|
|
23) Greulich H, Chen TH, Feng W, et al. Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med. 2005; 2: e313
|
|
|
|
|
|
24) Politi K, Zakowski MF, Fan PD, et al. Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. Genes & Dev. 2006; 20: 1496-510
|
|
|
|
|
|
25) Sakuma Y, Matsukuma S, Yoshihara M, et al. Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung. Mod Pathol 2007; 20: 967-73
|
|
|
|
|
|
26) Tang X, Varella-Garcia M, Xavier AC, et al. Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas. Cancer Prev Res (Phila Pa). 2008; 1: 192-200
|
|
|
|
|
|
27) Onozato R, Kosaka T, Kuwano H, et al. Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers. J Thorac Oncol. 2009; 4: 5-11
|
|
|
|
|
|
28) Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adeno-carcinoma. Nature. 2008; 455: 1069-75
|
|
|
|
|
|
29) Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448: 561-6
|
|
|
|
|
|
30) Mano H. Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer. Cancer Sci. 2008; 99: 2349-55
|
|
|
|
|
|
31) Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Mod Pathol. 2009; 22: 508-15
|
|
|
|
|
|
32) Takeuchi K, Choi YL, Togashi Y, et al. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer. Clin Cancer Res. 2009; 15: 3143-9
|
|
|
|
|
|
33) Rikova K, Guo A, Zeng Q, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007; 131: 1190- 203
|
|
|
|
|
|
34) Marks JL, McLellan MD, Zakowski MF, et al. Mutational analysis of EGFR and related signal-ing pathway genes in lung Adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4. PLoS One. 2007; 2: e426
|
|
|
|
|
|
35) Onozato R, Kosaka T, Achiwa H, et al. LKB1 gene mutations in Japanese lung cancer patients. Cancer Sci. 2007; 98: 1747-51
|
|
|
|
|
|
36) Kawai H, Ishii A, Washiya K, et al. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res. 2005; 11: 5084-9
|
|
|
|
|
|
37) Schwartz AG, Prysak GM, Murphy V, et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res. 2005; 11: 7280-7
|
|
|
|
|
|
38) Nose N, Sugio K, Oyama T, et al. Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung. J Clin Oncol. 2009; 27: 411-7
|
|
|
|
|
|
39) Ali G, Donati V, Loggini B, et al. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma. Hum Pathol. 2008; 39: 1465-73
|
|
|
|
|
|
40) Takeuchi T, Tomida S, Yatabe Y, et al. Expression profile-defined classification of lung adeno-carcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol. 2006; 24: 1679-88
|
|
|
|
|
|
41) Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007; 450: 893-8
|
|
|
|
|
|
42) Kendall J, Liu Q, Bakleh A, et al. Oncogenic cooperation and coamplification of develop-mental transcription factor genes in lung cancer. Proc Natl Acad Sci U S A. 2007; 104: 16663-8
|
|
|
|
|
|
43) Tanaka H, Yanagisawa K, Shinjo K, et al. Lineage-specific dependency of lung adeno-carcinomas on the lung development regulator TTF-1. Cancer Res. 2007; 67: 6007-11
|
|
|
|
|
|
44) Yatabe Y, Kosaka T, Takahashi T, et al. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am J Surg Pathol. 2005; 29: 633-9
|
|
|
|
|
|
45) Yatabe Y, Takahashi T, Mitsudomi T. Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. Cancer Res. 2008; 68: 2106-11
|
|
|
|
|
|
46) Soh J, Toyooka S, Ichihara S, et al. Sequential molecular changes during multistage patho-genesis of small peripheral adenocarcinomas of the lung. J Thorac Oncol. 2008; 3: 340-7
|
|
|
|
|
|
47) Sakamoto H, Shimizu J, Horio Y, et al. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol. 2007; 212: 287-94
|
|
|
|
|